All the latest news and information on the cannabis and psychedelics industries, with updates from the UK and across the globe.
And it’s no surprise! A number of psychedelic drugs are beginning to show promise in their ability to treat a wide range of symptoms and conditions. The attraction of mainstream…
When countries legalise cannabis, do people drink more alcohol than before, or less? That’s a question you might discuss, perhaps over drinks watching a match, or not at all, if…
In September 2022, Vobořil was tasked with creating a draft law for a legal adult recreational cannabis market, which is expected to be presented in March 2023, with full legalisation…
On 16 November the MHRA published a blog post outlining the guidance for companies applying for approval for unlicensed cannabis-based medicines in the UK. In this article we unpack the…
At Volteface we have talked extensively about the barriers to access the UK medical cannabis market, from a lack of awareness regarding legality to a shortfall in the number of…
In the first episode of Volteface TV Paul North, Director of Volteface speaks to Alastair Moore of The Hanway Company about the recently confirmed plans for cannabis legalisation in Germany.…
When the US midterms come around it’s always sure to be an interesting time for politics and drug policy, and this year’s midterms were no exception. Drugs were on the…
As we previously reported, Germany’s plans to legalise cannabis were leaked on 19th October. Key details from the unofficial documents and early-stage German proposals leaked to the press included: A…
Many psychological and neurological disorders are inadequately addressed by existing drugs. Treatment resistance affects around 20-60% of patients with a psychiatric disorder, and 33% of those suffering from a neurological…
Key aspects of the German government’s plans to create a legalised recreational cannabis market, following in the footsteps of countries such as Canada, Malta and Mexico have been leaked. These…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept